CN112426479A - 一种具有抗疲劳、增强免疫力功效的组合物及其用途 - Google Patents
一种具有抗疲劳、增强免疫力功效的组合物及其用途 Download PDFInfo
- Publication number
- CN112426479A CN112426479A CN202011285307.2A CN202011285307A CN112426479A CN 112426479 A CN112426479 A CN 112426479A CN 202011285307 A CN202011285307 A CN 202011285307A CN 112426479 A CN112426479 A CN 112426479A
- Authority
- CN
- China
- Prior art keywords
- composition
- fatigue
- effects
- ginseng
- resisting fatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000000694 effects Effects 0.000 title claims abstract description 67
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 230000036039 immunity Effects 0.000 title claims abstract description 39
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 38
- 241000208340 Araliaceae Species 0.000 claims abstract description 70
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 70
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 70
- 235000008434 ginseng Nutrition 0.000 claims abstract description 70
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 53
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 53
- 235000013353 coffee beverage Nutrition 0.000 claims abstract description 39
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 35
- 239000000843 powder Substances 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 230000002929 anti-fatigue Effects 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 235000013361 beverage Nutrition 0.000 claims description 18
- 230000002829 reductive effect Effects 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 15
- 241000756042 Polygonatum Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000003086 colorant Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 244000017020 Ipomoea batatas Species 0.000 claims description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 235000015190 carrot juice Nutrition 0.000 claims description 2
- 229960004106 citric acid Drugs 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 229960001790 sodium citrate Drugs 0.000 claims description 2
- 235000011083 sodium citrates Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 241000037831 Polygonatum sibiricum Species 0.000 claims 3
- 239000008213 purified water Substances 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 7
- 206010016256 fatigue Diseases 0.000 description 53
- 230000000052 comparative effect Effects 0.000 description 36
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 28
- 241000699670 Mus sp. Species 0.000 description 27
- 229920002527 Glycogen Polymers 0.000 description 26
- 229940096919 glycogen Drugs 0.000 description 25
- 239000000047 product Substances 0.000 description 22
- 238000012360 testing method Methods 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 241000282414 Homo sapiens Species 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 239000004310 lactic acid Substances 0.000 description 14
- 235000014655 lactic acid Nutrition 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 230000009182 swimming Effects 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 10
- 239000013589 supplement Substances 0.000 description 9
- 210000005036 nerve Anatomy 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 7
- 230000002440 hepatic effect Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010021143 Hypoxia Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 235000015897 energy drink Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 239000009609 fructus phyllanthi Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000002964 excitative effect Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000007954 hypoxia Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000037826 Polygonatum kingianum Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037080 exercise endurance Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000004110 gluconeogenesis Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- -1 hydroxyl free radical Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 208000008445 altitude sickness Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000376 effect on fatigue Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000003219 hemolytic agent Substances 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及一种具有抗疲劳、增强免疫力功效的组合物及其用途,按重量份计主要由以下原料制成:余甘子汁4份~5份,人参0.1份~0.2份,黄精0.1份~0.2份、咖啡粉0.1份~0.2份,所述余甘子汁的质量浓度≥98%,本发明组合物通过合理的配方达到了抗疲劳和增强免疫力的双重功效。
Description
技术领域
本发明涉及中药和保健品技术领域,具体涉及了一种具有抗疲劳、增强免疫力功效的组合物及其用途。
背景技术
随着社会竞争的加剧,生活节奏的加快,使人们常常倍感疲劳。长期处于疲劳状态,会损害人体的体力、体能,身体失衡,使人难以从事或完成某些消耗体力较大或动作细腻、精巧的工作,从而使工作效率下降;另一方面,长期疲劳还会使人皮肤松弛,面色无华,呈现出未老先衰的征兆;长期疲劳得不到恢复,使人体免疫系统功能失调,甚至造成免疫低下,机体抵抗疾病的屏障被打破,使患者患病的几率增加。
疲劳是指由于运动过度、缺乏睡眠、疾病等多种原因导致的机体机能的衰弱,主观上出现疲倦乏力、肌肉酸痛、失眠、心悸等不适感,并导致免疫能力低下、易患感冒、衰老加速、工作和学习能力下降。分为神经疲劳和机体疲劳,神经疲劳,是指神经使用过度,导致神经产生缺氧,出现工作、学习效率的下降、注意力变得不够集中、头昏,还会导致神经刺痛,严重的话会导致神经瘫痪。机体疲劳,是指定量的运动过后,一方面由于机体的氧消耗增大,机体得不到充分的能量而使肌肉乏力,另一方面,由于缺氧,机体产生大量的乳酸,使体内酸的积累,这样在细胞膜的氢钾交换泵的作用下细胞中的钾离子大量的外流,由于钾离子是细胞代谢不可或缺的,此时肌细胞的功能将会有一定的影响,肌纤维可表现为收缩力下降。
目前,国内市场上销售的抗疲劳产品名目繁多,产品抗疲劳作用普遍不显著,或者只解决了人体疲劳的表面问题,由于抗疲劳的产品大多属中枢神经兴奋剂的化学合成添加,长期服用,会出现服用量大,时效性差,消耗大脑和肌肉大量能量,造成身体处于透支状态,从而导致人体的免疫力下降的现象。
中药具有药性温和、不易耐药、适合长期服用等优点,因而较为适合处于亚健康状态人群的机体调节。因此,有必要开发一种能够化解抗疲劳功和增强免疫力的矛盾、同时兼顾两方面效果的中药组合物。
发明内容
本发明的目的在于:针对现有技术抗疲劳产品存在的抗疲劳效果不显著或难以兼顾抗疲劳和增强人体免疫力功效的技术问题,提供一种具有抗疲劳、增强免疫力功效的组合物及其用途。本发明创造性提出了多种活性成分相互协调配合促进的中药组合物配方,多种成分配伍可以发挥出既能抗疲劳又能增强免疫力的功效作用。同时本发明还提供了该组合物的用途,可以将本发明的组合物应用于各种保健养生产品或药物的制备当中。
为了实现上述目的,本发明采用的技术方案为:
一种具有抗疲劳、增强免疫力功效的组合物,按重量份计主要由以下原料制成:余甘子汁4份~5份,人参0.1份~0.2份,黄精0.1份~0.2份、咖啡0.1份~0.2份;所述余甘子汁的质量浓度≥98%。
余甘子系藏族习用药材,为大戟科植物余甘子的干燥成熟果实。据研究,余甘子中的没食子酸,具有抗氧化、减少自由基的作用,余甘子高ORAC(氧化自由基吸收能力)值(>38000/L)具有清除代谢废物——乳酸、血尿素氮等至疲物质和增强肝糖原、促进糖异生等功效。余甘子可以通过增加血中血红蛋白含量、调节脂肪能量供应比例,通过升高糖原储备量、节省糖原的消耗、清除致疲劳物质,起到抗疲劳的功效。
人参为多年生草本植物,性味甘、微苦,性温、平。归脾、肺经、心经。补气,固脱,生津,安神,益智。含18种人参皂苷、人参多糖、低聚肽、氨基酸、无机盐、维生素等。可以抗中枢神经递质紊乱,减少抑制性神经递质,增加兴奋性神经递质,提高思维和机体活动能力,不但能加强神经系统的兴奋作用,也能增强其抑制过程,使抑制趋于集中,分化完全从而使兴奋和抑制两种神经过程得以平衡,提高人的智力和体力的劳动效率;人参可以抑制自由基的产生,在人体剧烈运动时,会产生过多的自由基,氧自由基可与细胞膜多不饱和脂肪酸发生脂质过氧化反应,导致细胞结构和功能的破坏。人参不仅能抑制羟自由基(OH+),也能抑制阴离子自由基(O2-),防止运动后自由基对肝组织的损伤,加快对疲劳的消除作用;具有调节糖代谢,保证充足的肌、肝糖原,对抗血糖降低引起疲劳和减少乳酸堆积的作用。
黄精:黄精为黄精属植物。黄精中的黄精多糖通过黄精多糖通过增加肝糖原含量和快速清除血清尿素等代谢废物含量来缓解体力疲劳,并且抗自由基来减少氧化损伤,增强运动耐力,对抗机体疲劳。
咖啡可以兴奋中枢神经系统,振奋精神,提高注意、增强及警觉性,缓解精神疲劳,降低运动后血液乳酸浓度。
本发明提供的组合物以余甘子汁、人参、黄精和咖啡粉配伍,通过调整原料组分的添加量比例,使得组合物具有优秀的抗疲劳和增强免疫力的功效。《神农本草经》中记载:“人参,主补五脏,安精神,定魂魄,止惊悸,除邪气,明目,开心益智。久服,轻身延年。”人参甘温,归心、肺、脾、肾经,大补元气,善补益脾肾二脏之气,为补脾、肺气要药。黄精甘平,归脾、肺、肾经,具有养阴润肺、补脾益气、补肾益精的作用。两药配伍,一补一润,既可以中和人参的温燥之性,又可以增强补益作用,达到补脾益肾、养阴润燥的功效。脾肾之气得补,则先后天之气可相互资助,则中气、元气充沛。中气充足,则运化有力,可消除疲劳,元气充沛得以化成为形,则形体充实。气可化精,精又可化为气,精气可化为神,从而主宰人体生命活动。精盈则神明,气充则神明,正如《黄帝内经》倡导“积精全神”。而人参以补气为主,黄精以养精为要,二者合用,可令精气同补,精气充沛,则神可以得以滋养而发挥正常作用,起到极好的提神作用。余甘子,味甘性凉,有很好的消食健胃,生津止咳的作用,亦如《本草纲目》中所记载:“余甘子果,主补益气,久服轻身,延年益寿”,有良好的益气功效,能辅助人参增强补益作用。又因其性凉,可以中和人参的温性,合用可使药性平和,久服可避免上火。咖啡可提神醒脑,是家喻户晓的提神佳品。此方总起补气益精,提神醒脑,生津止渴之效。补益的精气充足,则神生化有源,在提神抗疲劳之时又无消耗人体精气之忧,且温凉合用,使其作用平和,可同时具有抗疲劳和增强免疫力的功效。
进一步的,所述人参是人工种植五年及以下的人参。
进一步的,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.05~0.1:1。经过发明人大量实验探究发现,人参和黄精的合计量与余甘子汁的量之比与组合物产品抗疲劳和增强免疫力的效果有着直接的关系,随着人参和黄精的量的增加,小鼠的耐力和活力均能不断的提高,但是余甘子汁比例相对过大的时候,耐力和活力会有所下降,优选地,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.06~0.1:1。更优选地,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.08~0.1:1。
进一步的,所述组合物还含有药学上可接受的载体和/或辅料。
进一步的,所述组合物的剂型为粉剂、饮品剂、泡腾剂、片剂或颗粒剂剂型。
本发明的另一目的是提供上述具有抗疲劳、增强免疫力功效的组合物的制备方法。
一种具有抗疲劳、增强免疫力功效的组合物的制备方法,包括以下步骤:
步骤1、按重量份称取澄清处理好的余甘子原汁,备用;
然后,按重量份称取人参、黄精,混合后加入10~15倍重量的水,加热至70~100℃下回流提取1~3次,每次1~2h,得到人参黄精浸膏;
步骤2、咖啡原料,干燥后粉碎,按重量份称取咖啡粉后加入10-15倍重量的水,加热至70~90℃下回流提取1-3次,将水提液减压浓缩至密度为1.03~1.05g/mL时,加入上述水提浸膏,继续减压浓缩至相对密度为1.05~1.10g/mL的浸膏;其中,浓缩条件:温度55℃~80℃,真空度0.04MPa~0.08MPa,蒸汽压,≤0.1MPa;浸膏喷完得到咖啡粉;
步骤3、将所述步骤1得到余甘子原汁、人参黄精浸膏与所述步骤2得到的咖啡粉混合,即得。
本发明配方科学,提供的组合物的制备方法,并且运用了高温回流提取、精制工艺,极大程度的提取出了人参、黄精的有效成份。制备方法简单便于工业化生产。
一种具有抗疲劳、增强免疫力功效的饮品,按重量份计主要由以下原料制成:具有抗疲劳、增强免疫力功效的组合物4份~6份,调味剂8份~15份,着色剂0份~5份,营养素0份~0.2份,水80份~90份。
本发明中的植物能量饮品配方中,各原料组分是一个有机的整体,缺一不可。发明人在研发过程中发现,减少上述配方中的任何一种原料组分,或以具有相似性质的其他原料组分对本发明配方中的原料组分进行替换,则配方整体的作用效果显著降低;在本发明配方的基础上再增加其他的原料组分,配方的整体效果并未有明显的改善,甚至有效果降低的情况出现。制备出可以缓解人体疲劳,增强免疫力的饮品具有十分重要的意义。
进一步的,所述调味剂为白糖、蜂蜜、柠檬酸、柠檬酸钠、安赛蜜、赤藓糖醇中的一种或多种。
进一步的,所述着色剂为蓝莓粉、紫甘薯粉、浓缩紫胡萝卜汁、柠檬黄、诱惑红中的一种或多种。
进一步的,所述营养素为维生素C、维生素B6与维生素B12、烟酰胺的中的一种或多种。
进一步的,具有抗疲劳、增强免疫力功效的饮品是由以下方法制备而成的:按重量份称取抗疲劳组合物、调味剂、着色剂、营养素,将调味剂进行30-50℃水热溶解,随后依次加入抗疲劳组合物、着色剂、营养素进行搅拌调配,加入水定量,经过均质、过滤、液体超高温瞬时灭菌、灌装、密封、即成。
本发明的另一目的是提供一种上述组合物的用途。
一种具有抗疲劳、增强免疫力功效的组合物在制备抗疲劳和增强免疫力的保健食品或药品中的用途。
与现有技术相比,本发明的抗疲劳组合物以余甘子为基础成分,辅以人参、黄精、咖啡粉等均衡配比,可添加到饮品、饮品、冲剂中,不添加咖啡因、牛磺酸、防腐剂、人工色素等,安全无副作用,能够增强人体免疫力,缓解疲劳。
综上所述,由于采用了上述技术方案,本发明的有益效果是:
1、本发明提供的组合物具有优秀的抗疲劳和增强免疫力的双重功效,弥补了现有中药组合物方案只能解决其一的不足。
2、本发明提供的组合物以余甘子汁、人参、黄精和咖啡粉配伍,人参以补气为主,黄精以养精为要,二者合用,可令精气同补,精气充沛,则神可以得以滋养而发挥正常作用,起到极好的提神作用。有良好的益气功效,能辅助人参增强补益作用。又因其性凉,可以中和人参的温性,合用可使药性平和,久服可避免上火。补益的精气充足,则神生化有源,在提神抗疲劳之时又无消耗人体精气之忧,且温凉合用,使其作用平和,可同时具有抗疲劳和增强免疫力的功效。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。
准备余甘子汁:川滇两省金沙江干热河谷地域的野生余甘子榨汁。
实施例1
一种具有抗疲劳、增强免疫力功效的饮品,通过以下方法制备得到:
(1)称取余甘子汁,浓度为99%,400g。
(2)称取人参20g、黄精20g,按照料液比为1:12的量加入12倍量(1g原料加入12mL水)的水加入480mL重量的水,加热至70-100℃下回流提取2次,每次1h,低温精制、醇化至人参黄精浸膏;即得。
(3)咖啡原料干燥粉碎,取14g咖啡粉加入10-15倍重量的水,加热至90℃下回流提取3次,将水提液减压浓缩至密度1.03~1.05g/mL(热测)时,加入上述水提浸膏,继续减压浓缩至相对密度为1.10g/mL(热测)的浸膏。浓缩条件:温度:65℃;真空度:0.08MPa;蒸汽压:≤0.1MPa。即得。
(4)将余甘子原汁、人参黄精液、咖啡提取液混合可组成抗疲劳组合物。
(5)取上述步骤的抗疲劳组合物500g,加入柠檬酸60g、蜂蜜40g、白砂糖1kg、柠檬酸钠20g等调味剂调配口味,静止,过滤,按照国家标准加入山梨酸钾4g防腐剂,定容至40L灌装,密封,灭菌,即成。
通过该实施例制备成的抗疲劳饮品主要适用于年龄在十四岁以上的易疲劳者,每日推荐饮用该抗疲劳保健饮品100mL,即可取得增强免疫力、抗疲劳等良好效果。
本实施例制备的饮品风味良好、无分层、稳定性高、营养损失小、色泽诱人口味清爽宜人,口感好,大肠菌群、霉菌、酵母和致病菌均无检出,微生物指标符合GB31326-2014规定,货架期达到12个月。
试验1:
抗疲劳饮品增强免疫力实验
使用上述实施例1和对比例1中制备的抗疲劳保健饮品进行增强免疫力的实验。
为了说明本发明的抗疲劳饮品有益效果,本发明采用小鼠能量补充试验来进行小鼠能量补充试验的试验原理是:将120只小鼠随机分为5组,分别为平原对照组、缺氧对照组、抗疲劳饮品低、中、高剂量组,其中抗疲劳饮品低、中、高剂量组按照实施例1抗疲劳饮品低、中、高(0.32、0.97、9.7ml/kg三个实验剂量),按照人体日推荐剂量换算成小鼠对应的实验剂量,低、中、高剂量分别相当于人体推荐剂量的0.3、1和10倍,每组24只。灌胃,1次/d,平原对照组和缺氧对照组给予等体积生理氯化钠溶液。平原对照组在重庆自然环境中(海拔300m)喂养,其余5组在模拟海拔5000m高度的动物低压舱中喂养,动物低压舱内温度25℃,相对湿度50%,光照12h/d。每天出舱1h灌胃、清洁、喂食,连续10d。实验期间动物自由饮水和摄食。然后进行肝糖原和血乳酸的测定。测定方法如下:
1.肝糖原测定
末次给予小鼠受试物30分钟后,立即处死。取肝脏经生理盐水漂洗后用滤纸吸干,精确称取肝脏200mg,加入4mL5%的三氯醋酸(TCA),每管匀浆1分钟,将匀浆液倒入离心管,3000转/分离心15分钟,将上清液转移至另一试管内。在沉淀中再加4mLTCA,匀浆1分钟,再次离心15分钟,取上清液,并与第一次离心的上清液合并,充分混匀。取1mL上清液放入10mL离心管中,每管加入95%的乙醇4mL,充分混匀至两种液体间不留有界面。用干净塞子塞上,室温下竖直放置过夜。沉淀完全后,将试管于3000转/分离心15分钟。小心倒掉上清液并使试管倒立放置10分钟。用2mL蒸馏水溶解糖原,加水时将管壁的糖原洗下,使之完全溶解。
2.血乳酸测定
末次给予小鼠受试物30分钟后,放入水温25℃、水深50cm的游泳箱中游泳10分钟后取出,即刻采尾血20μL,加入盛有40μL溶血剂的试管中混匀,用生物传感分析仪测定血乳酸值。采用同样的方法测定游泳前和游泳后休息20分钟时的血乳酸水平。
实验结果:
力竭游泳实验末次给饮品60min后,将小鼠置于游泳箱中,水深50cm,水温25±0.5℃,小鼠力竭游泳时间显著降低(P<0.05),肝糖原虽无显著性差异,但也呈下降趋势;与缺氧对照组相比,阳性对照明显延长力竭游泳时间(P<0.05)、促进肝糖原储备(P<0.05)和明显减小血乳酸曲线下面积(P<0.05)。结果显示模拟高原暴露小鼠疲劳评价模型结果稳定可靠,造模方法可行。
抗疲劳组合物对小鼠力竭游泳时间肝糖原含量及运动后血乳酸消除的影响余甘子低、高剂量组力竭游泳时间较缺氧对照组分别延长199.39%和168.8%(P<0.01),见表1。与缺氧对照组比较,余甘子低、中剂量组小鼠肝糖原含量增加了42.66%和42.43%(P<0.05)见表1。与缺氧对照组比较,饮品低剂量组血乳酸曲线下面积减少53.97%(P<0.01),见表1。
注:与平原对照组比较,bP<0.05;与缺氧对照组比较,fP<0.05,gP<0.01。
剧烈运动后机体处于缺氧状态,高原低氧环境更加剧了缺氧,体内会蓄积大量的致疲劳物质,如乳酸、血氨和血尿素氮等,这些物质的消除能使机体迅速恢复体能。糖原是运动能量的重要来源,糖原的储存量可直接影响机体的运动能力,提高糖原储备量有助于提高耐力和运动能力,有利于抵抗疲劳的产生。长时间紧张运动中体力的衰竭总是和肌糖原的耗竭同时发生,肌糖原耗竭的同时,为维持血糖水平肝糖原储备将减少,能增加肝糖原储备提供更多能量,因此肝糖原的含量能说明疲劳发生的快慢程度。运动耐力的提高是抗疲劳能力增强的最有力表现,游泳时间的长短可以反映运动疲劳的程度。
结果表明,在模拟高原环境下低剂量抗疲劳饮品(0.32ml/kg)能明显延长小鼠力竭游泳时间,显著促进运动后的乳酸消除,明显增加肝糖原储备,具有明显缓解体力疲劳的作用,而中剂量组(0.97ml/kg)仅有肝糖原明显增加,高剂量组余甘子可能通过提高乳酸脱氢酶的活性迅速清除血中乳酸,加强糖异生过程,将乳酸转变为葡萄糖或肝糖原,有效地降低运动后的乳酸水平,增强了肝糖原的储备。
试验2:
抗疲劳植物能量饮品增强抗疲劳力实验
使用上述实施例1中制备的抗疲劳能量植物饮品进行增强抗疲劳力的实验。
为了说明本发明的抗疲劳能量植物饮品有益效果,采用小鼠能量补充试验来进行小鼠能量补充试验的试验原理是:
第一步、让健康小鼠在运动后处于疲劳状态;
第二步、以蒸馏水和不同浓度的本发明抗疲劳植物能量饮品分别给小鼠喂养;
第三步、小鼠休息十分钟后进行耐力实验,比较得出运动效果的对比实验数据。
小鼠能量补充试验的试验步骤包括:
(1)将100只年龄相仿、体重相近(28-35g)的健康雄性小白鼠随机分为4组,每组25只,分别为空白组(以蒸馏水喂养),A组(喂养0.2ml的实施例1产品)、B组(喂养0.4ml实施例1产品)、C组(喂养0.6ml实施例1产品)。植物能量饮品为本发明实施例1制备的产品。
(2)设置老鼠跑笼,将老鼠跑笼置于水槽中,水的高度3-4厘米,水温15-20℃。
(3)当小鼠运动速度低于阈值(2圈/min)时即从笼中取出小鼠。按组别分别进行喂养,空白组灌以蒸馏水0.4ml、A组灌以0.3ml蒸馏水和0.1ml植物能量饮品、B组灌以0.2ml蒸馏水和0.2ml植物能量饮品、C组灌以0.1ml蒸馏水和0.3ml植物能量饮品。
(4)让小鼠休息10min后以同样方式刺激其跑步观察其体力恢复情况,并记录每分钟内小鼠的跑步圈数以及速度下降至2圈/min所需时间,得出实验结果并进行比较。
实验结果如下表2所示:
表2抗疲劳力的实验结果
表2中可见,A组、B组、C组分别与空白组比较有显著性差异,结果表明:补充本发明的运动能量饮品后,小鼠的耐力和活力均得到了补充,相对于空白对照有明显改善。
实施例2-4及对比例1-2
实施例2-4及对比例1-2按照实施例1相同的方法制备饮品,不同之处在于实施例实施例2-4及对比例1-2中的原料配比与实施例1的不同,但是实施例2-4及对比例1-2中人参与黄精、余甘子原汁的总质量不变,仅改变了人参与黄精的合计量占余甘子原汁的比例,原料配比如表3所示,将实施例2-4及对比例1-2制备得到的饮品产品采用上述试验中相同的增强抗疲劳力实验,其中,10只小白鼠为一组做实验,饲喂方式与上述试验中C组相同,并对测试结果进行了记录,如表3所示。
表3原料配比及测试结果
由表3中的数据可以看出,人参和黄精的合计量与余甘子汁的量之比与组合物产品抗疲劳和增强免疫力的效果有着直接的关系,随着人参和黄精的量的增加,小鼠的耐力和活力均能不断的提高,但是余甘子汁比例相对过大的时候,耐力和活力会有所下降,人参与黄精的合计量过小,小鼠耐力和活力提升力度不大。
优选地,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.06~0.1:1。
更优选地,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.08~0.1:1。
对比例4-7
对比例4相比实施例1来说,未添加人参,仅以余甘子汁、黄精和咖啡粉为原材料,对比例4余甘子汁、黄精和咖啡粉的总添加质量分别与实施例1中余甘子汁、人参、黄精和咖啡粉总质量相同,对比例4余甘子汁、黄精和咖啡粉的添加比例与实施例1中对应相同。
对比例5相比实施例1来说,未添加黄精,仅以余甘子汁、人参和咖啡粉为原材料,对比例4余甘子汁、人参和咖啡粉的总添加质量分别与实施例1中余甘子汁、人参、人参和咖啡粉总质量相同,对比例4余甘子汁、人参和咖啡粉的添加比例与实施例1中对应相同。
对比例6相比实施例1来说,未添加咖啡粉,仅以余甘子汁、黄精和人参为原材料,对比例4余甘子汁、黄精和人参的总添加质量分别与实施例1中余甘子汁、人参、黄精和人参总质量相同,对比例4余甘子汁、黄精和人参的添加比例与实施例1中对应相同。
对比例7相比实施例1来说,未添加余甘子汁,仅以咖啡粉、黄精和人参为原材料,对比例4咖啡粉、黄精和人参的总添加质量分别与实施例1中咖啡粉、人参、黄精和人参总质量相同,对比例4咖啡粉、黄精和人参的添加比例与实施例1中对应相同。
为了说明本发明中的抗疲劳植物原料缺一不可,本发明采用小鼠能量补充试验来进行小鼠能量补充试验的试验原理是:第一步、让健康小鼠在运动后处于疲劳状态;第二步、以蒸馏水为空白组和实施例1,对比例4,对比例5,对比例6,对比例7饮品分别给小鼠喂养;第三步、比较平均跑圈疲劳时间得出运动效果的对比实验数据。
小鼠能量补充试验的试验步骤包括:(1)将120只50±5日龄、体重相近(22±2g)的健康的雌雄各半的小白鼠随机分为6组,每组20只,分别为空白组(以蒸馏水喂养),实施例1组(以实施例1产品喂养)、对比例4组(以对比例4产品喂养)、对比例5组(以对比例5产品喂养)、对比例6组(以对比例6产品喂养)、对比例7组(以对比例7产品喂养)。植物能量饮品为本发明实施例1制备的产品。测试结果如表4所示。
表4测试结果
组合物配方 | 动物数(只) | 跑圈疲劳时间 | |
空白组 | 蒸馏水 | 20 | 4.0±0.8 |
实施例1 | 全部添加 | 20 | 7.2±0.4 |
对比例4 | 未添加人参 | 20 | 4.8±0.5 |
对比例5 | 未添加黄精 | 20 | 5.2±0.5 |
对比例6 | 未添加咖啡粉 | 20 | 5.4±0.4 |
对比例7 | 未添加余甘子汁 | 20 | 4.4±0.5 |
本发明提供的组合物以余甘子汁、人参、黄精和咖啡粉配伍,人参以补气为主,黄精以养精为要,二者合用,可令精气同补,精气充沛,则神可以得以滋养而发挥正常作用,起到极好的提神作用。有良好的益气功效,能辅助人参增强补益作用。又因其性凉,可以中和人参的温性,合用可使药性平和,久服可避免上火。补益的精气充足,则神生化有源,在提神抗疲劳之时又无消耗人体精气之忧,且温凉合用,使其作用平和,可同时具有抗疲劳和增强免疫力的功效。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种具有抗疲劳、增强免疫力功效的组合物,其特征在于,按重量份计主要由以下原料制成:余甘子汁4份~5份,人参0.1份~0.2份,黄精0.1份~0.2份、咖啡粉0.1份~0.2份,所述余甘子汁的质量浓度≥98%。
2.根据权利要求1所述的具有抗疲劳、增强免疫力功效的组合物,其特征在于,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.05~0.1:1。
3.根据权利要求2所述的具有抗疲劳、增强免疫力功效的组合物,其特征在于,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.06~0.1:1。
4.根据权利要求3所述的具有抗疲劳、增强免疫力功效的组合物,其特征在于,所述人参和所述黄精的合计量与所述余甘子汁的量之比为0.08~0.1:1。
5.根据权利要求1所述的具有抗疲劳、增强免疫力功效的组合物,其特征在于,所述组合物还含有药学上可接受的载体和/或辅料。
6.根据权利要求1-5任意一项所述的具有抗疲劳、增强免疫力功效的组合物,其特征在于,所述组合物的剂型为粉剂、饮品剂、泡腾剂、片剂或颗粒剂剂型。
7.一种如权利要求1-5任意一项所述的具有抗疲劳、增强免疫力功效的组合物的制备方法,包括以下步骤:
步骤1、按重量份称取澄清处理好的余甘子原汁,备用;
然后,按重量份称取人参、黄精,混合后加入10~15倍重量的水,加热至70~100℃下回流提取1~3次,每次1~2h,得到人参黄精浸膏;
步骤2、咖啡原料,干燥后粉碎,按重量份称取咖啡粉后加入10-15倍重量的水,加热至70~90℃下回流提取1-3次,将水提液减压浓缩至密度为1.03~1.05g/mL时,加入咖啡水提浸膏,继续减压浓缩至密度为1.05~1.10g/mL的浸膏,得到咖啡提取液;其中,浓缩条件:温度55℃~80℃,真空度0.04MPa~0.08MPa,蒸汽压,≤0.1MPa;
步骤3、将所述步骤1得到余甘子原汁、人参黄精浸膏与所述步骤2得到的咖啡提取液混合,即得。
8.一种具有抗疲劳、增强免疫力功效的饮品,按重量份计主要由以下原料制成:如权利要求7得到的具有抗疲劳、增强免疫力功效的组合物4份~6份,调味剂8份~15份,着色剂0份~5份,营养素0份~0.2份,纯净水80份~90份。
9.根据权利要求8所述的具有抗疲劳、增强免疫力功效的饮品,其特征在于,所述调味剂为白糖、蜂蜜、柠檬酸、柠檬酸钠、安赛蜜、赤藓糖醇中的一种或多种;
所述着色剂为蓝莓粉、紫甘薯粉、浓缩紫胡萝卜汁、柠檬黄、诱惑红中的一种或多种;
所述营养素为维生素C、维生素B6与维生素B12、烟酰胺的中的一种或多种。
10.权利要求1-6任意一项所述的具有抗疲劳、增强免疫力功效的组合物在制备抗疲劳和增强免疫力的保健食品或药品中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011285307.2A CN112426479A (zh) | 2020-11-17 | 2020-11-17 | 一种具有抗疲劳、增强免疫力功效的组合物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011285307.2A CN112426479A (zh) | 2020-11-17 | 2020-11-17 | 一种具有抗疲劳、增强免疫力功效的组合物及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112426479A true CN112426479A (zh) | 2021-03-02 |
Family
ID=74700675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011285307.2A Withdrawn CN112426479A (zh) | 2020-11-17 | 2020-11-17 | 一种具有抗疲劳、增强免疫力功效的组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112426479A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115736145A (zh) * | 2021-09-04 | 2023-03-07 | 山东省科学院生物研究所 | 一种抗疲劳功能饮料及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109329683A (zh) * | 2018-11-27 | 2019-02-15 | 浙江华康药业股份有限公司 | 一种运动能量饮料及其制作方法 |
-
2020
- 2020-11-17 CN CN202011285307.2A patent/CN112426479A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109329683A (zh) * | 2018-11-27 | 2019-02-15 | 浙江华康药业股份有限公司 | 一种运动能量饮料及其制作方法 |
Non-Patent Citations (1)
Title |
---|
张钢等: "余甘子对模拟高原环境小鼠抗疲劳作用的实验研究", 《解放军药学学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115736145A (zh) * | 2021-09-04 | 2023-03-07 | 山东省科学院生物研究所 | 一种抗疲劳功能饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104606612A (zh) | 一种解酒益肾压片糖果及其制备方法 | |
CN101284122A (zh) | 一种抗水土不服的软胶囊 | |
CN102524781A (zh) | 具有解酒作用的食用组合物及其制备方法 | |
CN106689933A (zh) | 一种富含天然成分提取物的解酒护肝饮料及其制备方法 | |
CN110934976A (zh) | 一种治疗近视的药物及其制备方法 | |
CN109077321A (zh) | 一种具有增强免疫力和抗氧化作用的组合物及其制备方法 | |
CN106106917A (zh) | 紫五加酵素茶及其制备方法 | |
CN103238889A (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
CN108143974A (zh) | 解酒护肝丸 | |
CN112426479A (zh) | 一种具有抗疲劳、增强免疫力功效的组合物及其用途 | |
CN108433108A (zh) | 一种六红素制剂及其制备方法 | |
CN108041397A (zh) | 一种提升睡眠质量的固体饮料 | |
CN104719537B (zh) | 一种花茶组合物及其制备方法 | |
CN113813313A (zh) | 一种具有解酒护肝功效的茶饮及其制备方法 | |
CN113632979A (zh) | 一种男女通用的四季养生饮料及其制备方法 | |
CN107183426B (zh) | 一种保肝解酒植物饮料、其制备方法及用途 | |
CN105168887A (zh) | 益肾养元软胶囊及制备工艺 | |
CN110496212A (zh) | 一种调理酒毒体质的中药组合物及其制备方法 | |
CN108497225A (zh) | 一种具有缓解体力疲劳功能的植物饮料及制备方法 | |
CN110025749A (zh) | 一种具有护发养发养生功能的中药组合物 | |
CN116270910B (zh) | 一种清暑补液补电解质抗疲劳组合物及其制备方法 | |
NL2037306B1 (en) | A nutritional product for clearing and protecting the lungs and a preparation method thereof | |
CN115607629B (zh) | 一种具有保肝解酒的中药组合物及其制备方法 | |
CN110755523B (zh) | 一种改善高血糖的组合物及其制备方法 | |
CN103907810A (zh) | 一种五红素制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210302 |
|
WW01 | Invention patent application withdrawn after publication |